Page last updated: 2024-10-21

4-aminobenzamidine and Antiphospholipid Syndrome

4-aminobenzamidine has been researched along with Antiphospholipid Syndrome in 1 studies

4-aminobenzamidine: a urokinase inhibitor; inhibits acrosin; structure given in first source

Antiphospholipid Syndrome: The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pozzi, N1
Acquasaliente, L1
Frasson, R1
Cristiani, A1
Moro, S1
Banzato, A1
Pengo, V1
Scaglione, GL1
Arcovito, A1
De Cristofaro, R1
De Filippis, V1

Other Studies

1 other study available for 4-aminobenzamidine and Antiphospholipid Syndrome

ArticleYear
β2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions.
    Journal of thrombosis and haemostasis : JTH, 2013, Volume: 11, Issue:6

    Topics: Anticoagulants; Antiphospholipid Syndrome; Benzamidines; beta 2-Glycoprotein I; Blood Coagulation; C

2013